Ruhl M , Himmelspach M , Bahr GM , Hammerschmid F , Jaksche H , Wolff B , Aschauer H , Farrington GK , Probst H , Bevec D .

Arrigo, Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. 1991, Pubmed

Arrigo, Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. 1991, Pubmed
Arya, Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). 1985, Pubmed
Bahr, Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies. 1985, Pubmed
Bartel, HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. 1991, Pubmed
Böhnlein, Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. 1991, Pubmed
Borer, Major nucleolar proteins shuttle between nucleus and cytoplasm. 1989, Pubmed , Xenbase
Chamot, Differential expression of genes encoding the hypusine-containing translation initiation factor, eIF-5A, in tobacco. 1992, Pubmed
Chang, Regulation by HIV Rev depends upon recognition of splice sites. 1989, Pubmed
Cochrane, Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. 1991, Pubmed
Cochrane, The human immunodeficiency virus rev protein is a nuclear phosphoprotein. 1989, Pubmed
Cochrane, Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. 1990, Pubmed
Cochrane, Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. 1990, Pubmed
Cook, Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. 1991, Pubmed
Cullen, Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. 1986, Pubmed
Cullen, Use of eukaryotic expression technology in the functional analysis of cloned genes. 1987, Pubmed
Cullen, Subcellular localization of the human immunodeficiency virus trans-acting art gene product. 1988, Pubmed
Daefler, Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA. 1990, Pubmed
D'Agostino, The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. 1992, Pubmed
Daly, Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. 1989, Pubmed
Devereux, A comprehensive set of sequence analysis programs for the VAX. 1984, Pubmed
Dumont, Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals. 1972, Pubmed , Xenbase
Emerman, The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. 1989, Pubmed
Feinberg, HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. 1986, Pubmed
Felber, rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. 1989, Pubmed
Gerace, Functional organization of the nuclear envelope. 1988, Pubmed
Gorman, Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. 1982, Pubmed
Gurdon, The use of Xenopus oocytes for the expression of cloned genes. 1983, Pubmed , Xenbase
Hadzopoulou-Cladaras, The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. 1989, Pubmed
Hammarskjöld, Regulation of human immunodeficiency virus env expression by the rev gene product. 1989, Pubmed
Hauber, Phosphorylation of the rev gene product of human immunodeficiency virus type 1. 1988, Pubmed
Heaphy, HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. 1990, Pubmed
Heaphy, Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. 1991, Pubmed
Hershey, The role of mammalian initiation factor eIF-4D and its hypusine modification in translation. 1990, Pubmed
Hope, Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. 1991, Pubmed
Hope, Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. 1990, Pubmed
Kjems, Specific binding of a basic peptide from HIV-1 Rev. 1992, Pubmed
Kjems, Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. 1991, Pubmed
Kjems, Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. 1991, Pubmed
Lawrence, The HIV-1 Rev protein: a model system for coupled RNA transport and translation. 1991, Pubmed
Lejbkowicz, A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. 1992, Pubmed
Maldarelli, Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. 1991, Pubmed
Malim, HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. 1990, Pubmed
Malim, Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. 1988, Pubmed
Malim, The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. 1989, Pubmed
Malim, HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. 1991, Pubmed
Malim, Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. 1989, Pubmed
Malim, Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. 1991, Pubmed
Mermer, Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. 1990, Pubmed
Olsen, Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. 1990, Pubmed
Olsen, Secondary structure is the major determinant for interaction of HIV rev protein with RNA. 1990, Pubmed
Park, Eukaryotic initiation factor 4D. Purification from human red blood cells and the sequence of amino acids around its single hypusine residue. 1986, Pubmed
Park, Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine. 1991, Pubmed
Park, The essential role of hypusine in eukaryotic translation initiation factor 4D (eIF-4D). Purification of eIF-4D and its precursors and comparison of their activities. 1989, Pubmed
Park, Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. 1993, Pubmed
Park, A monoclonal antibody against a family of nuclear pore proteins (nucleoporins): O-linked N-acetylglucosamine is part of the immunodeterminant. 1987, Pubmed
Ptashne, How eukaryotic transcriptional activators work. 1988, Pubmed
Rosen, Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. 1988, Pubmed
Sadaie, Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1. 1988, Pubmed
Schnier, Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. 1991, Pubmed
Schwartz, Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. 1992, Pubmed
Smith, Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. 1988, Pubmed
Smit-McBride, Sequence determination and cDNA cloning of eukaryotic initiation factor 4D, the hypusine-containing protein. 1989, Pubmed
Smit-McBride, Protein synthesis initiation factor eIF-4D. Functional comparison of native and unhypusinated forms of the protein. 1989, Pubmed
Sodroski, A second post-transcriptional trans-activator gene required for HTLV-III replication. , Pubmed
Terwilliger, The art gene product of human immunodeficiency virus is required for replication. 1988, Pubmed
Thach, Cap recap: the involvement of eIF-4F in regulating gene expression. 1992, Pubmed
Tiley, Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. 1992, Pubmed
Valent, Interleukin 4 promotes expression of mast cell ICAM-1 antigen. 1991, Pubmed
Venkatesh, Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. 1990, Pubmed
Weichselbraun, Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. 1992, Pubmed
Weiss, Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k. 1989, Pubmed
Wolff, Two isoforms of eIF-5A in chick embryo. Isolation, activity, and comparison of sequences of the hypusine-containing proteins. 1992, Pubmed
Yamasaki, Identification of four nuclear transport signal-binding proteins that interact with diverse transport signals. 1989, Pubmed , Xenbase
Zapp, Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. 1991, Pubmed
Zapp, Sequence-specific RNA binding by the HIV-1 Rev protein. 1989, Pubmed